View Alert
Originator: MHRA Dear Doctor Letter

From: Dr Ian Hudson

Issue date: 22-Oct-2018 18:48:37

Action by recipients:
  • NHS Trusts (England) - Medical Director
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • CMO Urgent Messages - Recipients on Public Health Link
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Foundation Trusts (England) - Chief Executive
  • NHS Trusts (England) - Chief Executive
  • NHS Regional Offices

Information to recipients:
  • Special Health Authorities
  • Other contacts
  • Director of Public Health
  • Social Care Providers (registered with CAS)
  • Independent Healthcare Providers (registered with CAS)
  • CMO Urgent Messages - Non-NHS Recipients on Public Health Link
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Clinical Commissioning Groups

Action category: Action within 48 hours

Title: Valproate Pregnancy Prevention Programme - an update for pharmacists

Broadcast content: In April 2018 an alert was issued relating to the Valproate Pregnancy Prevention Programme. We are issuing the attached information to pharmacists to remind them of the resources available, including statutory patient information leaflets and the importance of making these available to patients.

This letter should be shared with all pharmacists within your organisation.

Additional information: NHS England Regional Offices: please cascade to community pharmacy

Alert reference: DDL/Valproate/October-2018

Cascade to:
  • #HospitalPharmacy#

Contact our helpdesk


Medicines and Healthcare products Regulatory Agency